Biofourmis
Headquarters
Boston, MAFounded
2015CEO / Founder
David KoretzEmployees
201-500Funding
Series D+ — $445MProducts
1 product listedAvg. AI Score
7.6/10Website
www.biofourmis.com
Profile updated
About Biofourmis
Biofourmis is a digital health company founded in 2015 by Kuldeep Singh Rajput and headquartered in Boston, Massachusetts. The company develops software and services for remote patient monitoring, hospital-at-home programs, and virtual care delivery, targeting health systems, pharmaceutical companies, and payers.
The company's core platform, Biovitals, uses biosensor data and machine learning models to detect physiological changes in patients with conditions such as heart failure, cancer, and post-surgical recovery. Biofourmis has partnered with health systems including Brigham and Women's Hospital and has worked with pharmaceutical companies to support decentralized clinical trials. Its hospital-at-home offering enables acute-level care to be delivered outside traditional inpatient settings.
Biofourmis raised a $300 million Series D round in 2021, bringing its total funding to approximately $445 million and valuing the company at over $1 billion. In 2022, the company acquired Curavi Health, a telehealth provider focused on skilled nursing facilities. The company has expanded operations across the United States, Europe, and Asia-Pacific.
Specialties
Financials
Dated, source-cited figures. Estimates are marked.
Products by Biofourmis
All products by Biofourmis reviewed by our AI panel of experts.
How Our Review Panel Scores Biofourmis
Six independent reviewer personalities assessed Biofourmis's product on their own terms. They disagreed by 2.0 points — The Finance Lead was the hardest to convince, The Domain Strategist the most positive.
Averaged across 1 reviewed product in our catalog. Scores are out of 10.
Competitive Landscape
Who Biofourmis competes with, and how they differ.
Medically Home supplies the command-center logistics, supply-chain, and payer/health-system network that turns a patient's home into a hospital room, whereas Biofourmis (now merged with CopilotIQ) leads with its FDA-cleared Biovitals AI monitoring and analytics software layered onto in-home clinical engagement.
Company Timeline
Key milestones in Biofourmis's history, with sources.
- Milestone
Former CEO Kuldeep Singh Rajput charged with $16.5M invoice fraud
Singapore police charged Biofourmis co-founder and former CEO Kuldeep Singh Rajput with fraud and forgery over invoices allegedly falsified to the Ministry of Health worth about US$16.5 million, tied to conduct in 2021-2022.
businesstimes.com.sg - Acquisition
ActiGraph acquires Biofourmis' life science clinical-trial business
Wearable maker ActiGraph acquired Biofourmis's clinical-trial technology assets in a deal it called transformational for clinical trial modernization, as Biofourmis narrowed focus to care delivery.
statnews.com - Milestone
Merges with CopilotIQ to form combined in-home care platform
Biofourmis merged with in-home care software company CopilotIQ; the combined company, backed by General Atlantic, Openspace Ventures and Bessemer Venture Partners, is led by CEO David Koretz.
bernama.com - Partnership
Partners with GE HealthCare on at-home patient monitoring
GE HealthCare and Biofourmis announced a collaboration to extend GE's inpatient monitoring portfolio into virtual, at-home patient care.
finance.yahoo.com - Milestone
Co-founder Kuldeep Singh Rajput steps down as CEO after 120 layoffs
Biofourmis confirmed co-founder Kuldeep Singh Rajput stepped down as CEO one month after the company cut about 120 jobs worldwide (48 in the US); General Atlantic board member Ben Wanamaker took over a newly formed CEO office.
statnews.com - Funding
Series D -- $300M led by General Atlantic, reaches unicorn status
Biofourmis raised a $300M Series D led by General Atlantic, pushing its valuation to about $1.3B and cumulative funding to roughly $445M.
medcitynews.com - Funding
Series C -- $100M led by SoftBank Vision Fund 2
Biofourmis raised $100M in a Series C round led by SoftBank Vision Fund 2 to expand its AI-based remote patient monitoring platform.
venturebeat.com - Acquisition
Acquires Takeda's oncology digital health tool Gaido Health
Biofourmis acquired Gaido Health, an oncology-focused digital health tool developed by Takeda, expanding the company into cancer care.
mobihealthnews.com - Partnership
Commercialization partnership with Novartis for heart-failure digital therapeutics
Biofourmis and Novartis struck a deal to commercialize Biofourmis's digital therapeutics platform for heart failure patients.
businessinsider.com - Acquisition
Acquires Swiss wearable maker Biovotion AG
Biofourmis acquired Zurich-based wearable sensor maker Biovotion AG, completing its Biovitals platform for continuous physiological monitoring.
mobihealthnews.com - Funding
Series B -- $35M, relocates HQ to Boston
Biofourmis raised a $35M Series B, bringing total funding to about $41.6M, and relocated its headquarters from Singapore to Boston while keeping a Singapore engineering office.
techcrunch.com - Founded
Founded in Singapore by Kuldeep Singh Rajput and Wendou Niu
Kuldeep Singh Rajput, who had moved to Singapore to pursue a PhD, dropped out to co-found Biofourmis with Wendou Niu to predict disease onset from physiological and clinical data.
techcrunch.com
Explore AI Software Reviews
Browse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.